Antihypertensive AgentsAmlodipineFelodipineHypertensionHydrochlorothiazideBlood PressureTetrazolesBlood Pressure Monitoring, AmbulatoryCalcium Channel BlockersDouble-Blind MethodAngiotensin II Type 1 Receptor BlockersTreatment OutcomeDrug Therapy, CombinationHeart RateDiureticsAngiotensin-Converting Enzyme InhibitorsAtenololMethyldopaSodium Chloride Symporter InhibitorsRats, Inbred SHRChlorthalidoneHydralazineDoxazosinLisinoprilAdrenergic beta-AntagonistsEnalaprilBlood Pressure DeterminationCaptoprilTrichlormethiazideHypertension, RenalThiazidesLosartanAngiotensin Receptor AntagonistsDihydropyridinesIndapamideBenzimidazolesTime FactorsBendroflumethiazideBenzothiadiazinesRats, Inbred WKYLabetalolDose-Response Relationship, DrugFollow-Up StudiesNifedipinePatient ComplianceHypertrophy, Left VentricularRisk FactorsProspective StudiesReninBiphenyl CompoundsMinoxidilMedication AdherenceSystoleClinical Trials as TopicPerindoprilClonidineRamiprilRenin-Angiotensin SystemAdministration, OralCilazaprilNicardipineDrug CombinationsCardiovascular DiseasesHypertension, RenovascularKidneyRandomized Controlled Trials as TopicDrug Administration ScheduleCohort StudiesRetrospective StudiesAlbuminuriaKidney Failure, ChronicAdrenergic alpha-AntagonistsImidazolesNordefrinHypertension, MalignantNitrendipineDrug UtilizationPulsePropranololDrug PrescriptionsPropanolaminesDesoxycorticosteronePlacebosAzetidinecarboxylic AcidDiabetic NephropathiesThiazepinesGuanfacineValineFumaratesUnited StatesApium graveolensProteinuriaReserpineBenzoatesDiabetes Mellitus, Type 2Drug ChronotherapyPeptidyl-Dipeptidase APrazosinAge FactorsFosinopril